Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Joshua S. BogerDirector | CervoMedCRVO | Open-market buy | 06/11 | 06/15 | 955,414 sh | $3.14 | $2,999,999.96 | +113.7% |
CervoMedCRVO | Open-market buy | 25/11/17–25/11/18 | 25/11/19 | 3,500 sh2 trades | $8.36avg. | $29,250 | +38.9% | |
CervoMedCRVO | Open-market buy | 25/11/17–25/11/18 | 25/11/19 | 5,000 sh2 trades | $8.29avg. | $41,430 | +50.0% | |
CervoMedCRVO | Open-market buy | 25/11/17 | 25/11/19 | 21,600 sh2 trades | $8.46avg. | $182,736 | No record | |
CervoMedCRVO | Open-market buy | 25/11/17 | 25/11/19 | 21,600 sh2 trades | $8.46avg. | $182,736 | No record | |
CervoMedCRVO | Open-market buy | 25/11/13–25/11/14 | 25/11/17 | 7,847 sh3 trades | $7.53avg. | $59,101.11 | No record | |
CervoMedCRVO | Open-market buy | 25/11/13–25/11/14 | 25/11/17 | 7,847 sh3 trades | $7.53avg. | $59,101.11 | No record | |
Matthew WintonChief Commercial and Business | CervoMedCRVO | Open-market buy | 25/11/14 | 25/11/17 | 10,000 sh | $7.57 | $75,700 | No record |
John J. AlamCEO & President | CervoMedCRVO | Open-market buy | 25/11/12 | 25/11/13 | 5,553 sh | $7.35 | $40,814.55 | +0.4% |
Sylvie GregoireDirector | CervoMedCRVO | Open-market buy | 25/11/12 | 25/11/13 | 5,553 sh | $7.35 | $40,814.55 | +0.4% |
William Robert ElderCFO, GC & Secretary | CervoMedCRVO | Open-market buy | 25/11/12 | 25/11/13 | 3,500 sh | $7.44 | $26,040 | +63.6% |
William Robert ElderCFO, GC & Secretary | CervoMedCRVO | Open-market buy | 25/05/14 | 25/05/14 | 4,233 sh | $8.46 | $35,811.18 | +334.1% |
William Robert ElderCFO & Gc | CervoMedCRVO | Open-market buy | 24/08/27 | 24/08/27 | 1,000 sh | $18.16 | $18,160 | +374.5% |
Joshua S. BogerDirector | CervoMedCRVO | Open-market sale | 24/02/26 | 24/02/28 | 36 sh | In footnote | No stated value | −0.0% |